SRS Capital Advisors »

Amylyx Pharmaceuticals shares owned by SRS Capital Advisors

Quarter-by-quarter ownership of Amylyx Pharmaceuticals (AMLX) shares owned by SRS Capital Advisors from 13F filings

Historical chart of SRS Capital Advisors investment in Amylyx Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amylyx Pharmaceuticals held by SRS Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amylyx Pharmaceuticals by SRS Capital Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $7.1k 2.2k 3.24
2024-06-30 $4.2k 2.2k 1.90

More positions owned by SRS Capital Advisors

Vanguard Index Fds Value Etf (VTV)
Ishares Tr Ishs 1-5yr Invs (IGSB)
Schwab Strategic Tr Us Tips Etf (SCHP)
Vanguard Index Fds Growth Etf (VUG)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Core Us Aggbd Et (AGG)
Dimensional Etf Trust Core Fixed Incom (DFCF)
Vanguard Index Fds Mid Cap Etf (VO)
First Tr Exch Traded Fd Iii Pfd Secs Inc Etf (FPE)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Vanguard Index Fds Small Cp Etf (VB)
Ishares Tr S&p 500 Val Etf (IVE)

View all positions for SRS Capital Advisors

Top funds holding Amylyx Pharmaceuticals

Vanguard Group
BlackRock
Goldman Sachs Group
BlackRock
Citadel Advisors
Perceptive Advisors
Alyeska Investment Group
683 Capital Management
Almitas Capital
Standard Life Aberdeen
Acadian Asset Management
Nantahala Capital Management
Two Sigma Investments
Two Sigma Advisers
Farallon Capital Management

View all funds holding Amylyx Pharmaceuticals